US LNG exports surge but will buyers in China turn up?
Saba Capital Management, L.P., led by Boaz Weinstein, recently added to its holdings in Gabelli Healthcare & WellnessRx Trust (NYSE:GRX). According to a Form 4 filing with the Securities and Exchange Commission, the firm purchased 1,100 shares of common stock at a price of $9.24 per share, totaling approximately $10,164.
This transaction increases Saba Capital’s stake in the trust, with the firm now holding a total of 1,970,744 shares. The acquisition reflects Saba Capital’s ongoing investment strategy in the healthcare and wellness sector. The trust, which has maintained dividend payments for 14 consecutive years, is currently trading near its 52-week low of $9.03, despite posting a 6.53% total return over the past year.
Saba Capital, known for its strategic investments, continues to be a significant shareholder, owning more than ten percent of Gabelli Healthcare & WellnessRx Trust. The transaction was executed on April 11, 2025, and the filing was signed by Zachary Gindes on behalf of Saba Capital, as well as by Boaz Weinstein.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.